For three decades, public-health messages have rightly emphasized UV skin damage and photoprotection. In parallel, several cohorts associate more time outdoors, daytime light, or sun-seeking behavior with lower mortality. These exposures are not equivalent, and these associations do not show that sun avoidance causes deaths: they invite us to distinguish daylight, UV, and vitamin D.
What the large cohorts show
The Swedish MISS cohort: the initial shock
The Swedish MISS cohort (Melanoma in Southern Sweden) followed 29,518 women for 20 years and classified them by reported sun-exposure habits. In the analysis published in the Journal of Internal Medicine in 2014, women who avoided the sun had twice the all-cause mortality of those in the highest exposure group (PubMed). This is an observational association, not a randomized comparison of a sun prescription.
In 2016, a competing-risk analysis of the same cohort observed that nonsmoking women who avoided the sun had a life expectancy comparable to smokers in the highest-exposure group (PubMed). This magnitude comparison does not mean avoidance is causally equivalent to smoking or that seeking more UV cancels that risk.
In this cohort of Swedish women, those who reported avoiding the sun had twice the all-cause mortality risk of the highest-exposure group; this observational result does not establish causality.
The Adventist cohort: the reverse J-curve
The North American AHS-2 study (Adventist Health Study 2, published 2025) confirmed and refined these results in 83,205 participants followed for approximately 11 years. Compared to 30 minutes per day outdoors, spending about 2 hours daily in natural light was associated with a 10% reduction in all-cause mortality, 11% in cardiovascular mortality, and 17% in non-cancer, non-cardiovascular mortality (PubMed).
The estimated relationship follows a reverse J-shaped curve, with the lowest mortality around 1.5 to 2.5 hours outdoors each day. That duration concerns time in daylight in this cohort: it measures neither UV dose nor a window of skin exposure and therefore does not become a sun prescription.
UK Biobank: objectively measured light
A 2024 study of 88,905 UK Biobank participants used wrist-worn light sensors over 13 million cumulative hours. Individuals exposed to intense daytime light had a mortality risk reduced by between 17% and 34% compared to the least exposed. Symmetrically, high nighttime light exposure increased risk by between 21% and 34% (PubMed).
A second UK Biobank analysis, focused specifically on UV exposure, showed that individuals reporting the most sun-seeking behavior had 14% lower all-cause and cancer mortality, and 19% lower cardiovascular mortality (PubMed).
These cohorts from several countries converge on an association, but they measure different exposures—time outdoors, wrist light, or reported behavior—and remain observational. Their consistency strengthens a hypothesis; it is not enough to set a UV duration or prove a causal mortality effect.
The sedentarity objection
People who go outside more also differ in activity, health, and social context. The analyses adjust for several of these variables: MISS for BMI, income, education, smoking, and alcohol; AHS-2 for activity, diet, and ethnicity; UK Biobank uses wrist sensors. The association persists after adjustment, but residual confounding, selection, and measurement error remain possible.
Laboratory mechanisms—cutaneous nitric oxide, beta-endorphins, and circadian synchronization—add plausibility. The Liu and Weller study is indeed interventional for UVA exposure and the acute blood-pressure response; it randomizes neither long-term sun habits nor mortality. A short biological effect therefore does not demonstrate the causal effect suggested by cohorts.
Beyond vitamin D: four independent mechanisms
The initial hypothesis was simple: sun produces vitamin D, which would explain associations with chronic disease. Randomized vitamin D supplementation trials do not reproduce the cardiovascular associations observed with sun exposure (PubMed). This makes that explanation insufficient without proving that UV, in turn, causes a clinical benefit.
1. Cutaneous nitric oxide and blood pressure
Human skin stores significant reserves of nitrates and nitrites in the epidermis. Under UVA exposure, these compounds release nitric oxide (NO), a potent vasodilator. Richard Weller's team at the University of Edinburgh demonstrated in humans that standard UVA exposure causes a significant decrease in systolic and diastolic blood pressure, with a measurable increase in forearm blood flow (PubMed).
This mechanism is independent of vitamin D synthesis (which requires UVB, not UVA) and independent of nitric oxide synthase (NOS). It is a direct photochemical pathway. Given that hypertension is the leading risk factor for cardiovascular death worldwide, the potential population-level impact is considerable.
The MISS cohort confirmed this relationship in 2021: women with low sun exposure had a 41% higher risk of hypertension than those most exposed, with a dose-dependent relationship (PubMed).
2. Beta-endorphins and reward circuitry
In 2014, a study published in Cell showed that UV exposure triggers beta-endorphin secretion from epidermal keratinocytes, via p53-mediated pro-opiomelanocortin (POMC) induction. These cutaneous endorphins enter the bloodstream and activate systemic opioid receptors (PubMed).
This mechanistic study also found signs of opioid dependence in mice after chronic UV exposure, with withdrawal under naloxone. It documents a biological pathway and possible behavioral reinforcement; it does not support prescribing sun as an analgesic or anxiolytic in humans.
3. Circadian synchronization
Natural light is a major synchronizer of the central circadian clock. Morning daylight contributes to setting the sleep-wake cycle. In UK Biobank, brighter daytime light is associated with several favorable indicators while nighttime light is associated with unfavorable outcomes; these associations alone do not confirm a causal mortality effect.
This mechanism has nothing to do with UV. It operates through melanopsin in intrinsically photosensitive retinal ganglion cells (ipRGCs), which detect ambient blue light. It explains why even on overcast days, going outside is beneficial: outdoor light intensity (10,000+ lux) exceeds that of a lit interior (300-500 lux) by a factor of 20 to 50.
4. Immune modulation
UV light modulates the activity of cutaneous immune cells, including Langerhans cells and regulatory T lymphocytes. This mechanism contributes to supervised phototherapy for some skin diseases, with medical doses and indications. It does not show that unsupervised sun exposure reduces chronic inflammation or extends life.
The cutaneous price: photoaging
Photoaging is real, documented, and visible. A study published in the New England Journal of Medicine in 1997 detailed the mechanism: UV rays activate matrix metalloproteinases (MMP-1, MMP-3, MMP-9) that degrade dermal collagen. UVA, which penetrates deep into the dermis, is the primary culprit via oxidative stress. UVB, more superficial, causes direct DNA damage (pyrimidine dimers) (PubMed).
The clinical result is familiar: deep wrinkles, pigmentation spots, loss of elasticity, actinic keratoses. The face, neck, and hands (chronically exposed areas) age faster than the torso or thighs.
Skin cancers do not all have the same lethality, but that difference does not make UV harmless. Intermittent sunburn, especially in childhood, is an important melanoma risk factor; cumulative exposure also contributes to photoaging and other skin cancers. These established risks cannot be offset for an individual by a mortality association from a cohort.
Why there is no universal UV window
The data distinguish daylight, UV, and vitamin D but do not define a universal therapeutic protocol for sun exposure:
Duration: cutaneous synthesis varies widely, and no fixed duration guarantees a given amount of vitamin D (PubMed). The proposal of 15 to 30 minutes without sunscreen and its 10,000-to-20,000-IU equivalence are not a defensible prescription. The practical priority remains avoiding sunburn and using appropriate photoprotection.
Timing: midday often raises the UV index and therefore the speed of skin damage. Morning daylight can support circadian timing without seeking a high UV index. A UVB/UVA ratio does not make midday a therapeutic window.
Skin phototype: it changes the rate of synthesis and susceptibility to sunburn, but no fraction of the minimal erythemal dose is a guaranteed “benefit without damage” boundary. Molecular damage can occur before visible redness; personal history and photosensitizing treatments also matter.
Season and latitude: cutaneous synthesis generally decreases in winter at the latitudes of continental France, with variable magnitude. Season helps interpret a 25(OH)D result; it is not enough to diagnose deficiency or trigger D3 supplementation. At Singular, only the current result determines the biological D3 tier.
Protection: clothing, shade, and broad-spectrum sunscreen reduce UV exposure during higher-risk periods. There is no initial “therapeutic” phase during which protection should be removed. Outdoor activity for daylight can be organized without seeking a UV dose on bare skin.
UV dose and vitamin D synthesis depend on context. Cohorts do not establish an unprotected window that maximizes benefit while guaranteeing the absence of skin damage.
What these data change
The data invite us to move beyond a false choice between permanent indoor living and seeking UV. Daylight, skin UV exposure, and vitamin D status are three related but distinct variables. Cohorts document associations; they do not prove that an optimal UV window exists or that it would be narrow and universal.
The useful question is therefore not how many minutes of bare skin to prescribe, but how to separate objectives: seek daylight for circadian timing, limit UV damage through photoprotection, and interpret measured 25(OH)D without automatic seasonal supplementation. Current evidence cannot convert those objectives into one universal number of minutes.
Research also documents distinct pathways: D3 raises 25(OH)D, visible light synchronizes the circadian clock, and UVA can release cutaneous nitric oxide or activate other responses. A D3 tablet does not reproduce those exposures, but their existence does not demonstrate that seeking more UV causally improves longevity.
Frequently asked questions
References
- Lindqvist PG, Epstein E, Landin-Olsson M, et al. Avoidance of sun exposure is a risk factor for all-cause mortality: results from the Melanoma in Southern Sweden cohort. J Intern Med. 2014;276(1):77-86 (PubMed).
- Lindqvist PG, Epstein E, Nielsen K, et al. Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohort. J Intern Med. 2016;280(4):375-387 (PubMed).
- Nazeeh N, Orlich MJ, Segovia-Siapco G, et al. The association between time spent outdoors during daylight and mortality among participants of the Adventist Health Study 2 Cohort. Environ Epidemiol. 2025;9(3):e401 (PubMed).
- Windred DP, Burns AC, Lane JM, et al. Brighter nights and darker days predict higher mortality risk: A prospective analysis of personal light exposure in >88,000 individuals. Proc Natl Acad Sci USA. 2024;121(43):e2405924121 (PubMed).
- Stevenson AC, Clemens T, Pairo-Castineira E, et al. Higher ultraviolet light exposure is associated with lower mortality: An analysis of data from the UK biobank cohort study. Health Place. 2024;89:103328 (PubMed).
- Scragg R, Rahman J, Thornley S. Association of sun and UV exposure with blood pressure and cardiovascular disease: a systematic review. J Steroid Biochem Mol Biol. 2019;187:68-75 (PubMed).
- Liu D, Fernandez BO, Hamilton A, et al. UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol. 2014;134(7):1839-1846 (PubMed).
- Lindqvist PG, Landin-Olsson M, Olsson H. Low sun exposure habits is associated with a dose-dependent increased risk of hypertension. Photochem Photobiol Sci. 2021;20:285-292 (PubMed).
- Fell GL, Robinson KC, Mao J, et al. Skin β-endorphin mediates addiction to UV light. Cell. 2014;157(7):1527-1534 (PubMed).
- Fisher GJ, Wang ZQ, Datta SC, et al. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997;337(20):1419-1428 (PubMed).
- Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol. 2013;5(1):51-108 (PubMed).
